AR059836A1 - Beta-agonistas enantiomericamente puros, y su uso como medicamentos - Google Patents
Beta-agonistas enantiomericamente puros, y su uso como medicamentosInfo
- Publication number
- AR059836A1 AR059836A1 ARP070101031A ARP070101031A AR059836A1 AR 059836 A1 AR059836 A1 AR 059836A1 AR P070101031 A ARP070101031 A AR P070101031A AR P070101031 A ARP070101031 A AR P070101031A AR 059836 A1 AR059836 A1 AR 059836A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- enantiomerically pure
- tautomers
- haloalkyl
- medicines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Suspension/Interruption
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Su preparacion como medicamentos, en especial como medicamentos para el tratamiento de enfermedades de las vías respiratorias. Reivindicacion 1: Compuestos enantioméricamente puros de la formula (1) donde n significa 1, 2, 3 o 4; X CH2, CO, NR2, S u O; B un grupo de enlace doble de la formula CR3R4-O; R1 H, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, cicloalquilo C3-6, haloalquilo C1-6, O-haloalquilo C1-6, halogeno, OH, CN, NO2, O-alquilo C1-6, COOH o COO-alquiIo C1-4-; R2 H, alquilo C1-6, alquilen C1-4-arilo C6-10 o alquilen C1-4-cicloalquilo C3-6, con preferencia H o alquilo C1-6; R3 H o alquilo C1-6, R4 H o alquilo C1-6, Ym- un anion cargado negativamente m veces, con preferencia un anion cargado negativamente m veces seleccionado del grupo compuesto por cloruro, bromuro, yoduro, sulfato, fosfato, metansulfonato, nitrato, maleinato, acetato, benzoato, citrato, salicilato, trifluoroacetato, fumarato, tartrato, oxalato, succinato, etandisulfonato, propandisulfonato, benzoato y p-toluensulfonato, m 1 o 2 eventualmente en forma de sus tautomeros, mezclas de los tautomeros, hidratos o solvatos.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06111191 | 2006-03-15 | ||
| EP06111342 | 2006-03-17 | ||
| EP06111338 | 2006-03-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR059836A1 true AR059836A1 (es) | 2008-04-30 |
Family
ID=38006901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070101031A Suspension/Interruption AR059836A1 (es) | 2006-03-15 | 2007-03-14 | Beta-agonistas enantiomericamente puros, y su uso como medicamentos |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7534789B2 (es) |
| EP (1) | EP1996581A1 (es) |
| JP (1) | JP2009530245A (es) |
| KR (1) | KR20080106973A (es) |
| AR (1) | AR059836A1 (es) |
| AU (1) | AU2007224420A1 (es) |
| BR (1) | BRPI0709601A2 (es) |
| CA (1) | CA2643026A1 (es) |
| EA (1) | EA200801894A1 (es) |
| EC (1) | ECSP088723A (es) |
| MX (1) | MX2008011700A (es) |
| NO (1) | NO20083508L (es) |
| PE (1) | PE20080142A1 (es) |
| TW (1) | TW200804360A (es) |
| UY (1) | UY30207A1 (es) |
| WO (1) | WO2007104772A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7799336B2 (en) | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
| PE20080142A1 (es) * | 2006-03-15 | 2008-04-14 | Boehringer Ingelheim Int | Beta-agonistas enantiomericamente puros y sus procedimientos de preparacion |
| KR102307281B1 (ko) | 2013-10-31 | 2021-09-29 | 알레간 인코포레이티드 | 프로스타마이드-함유 안구내 삽입물 및 그것의 사용 방법 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2609645A1 (de) * | 1976-03-09 | 1977-09-15 | Boehringer Sohn Ingelheim | Aminoalkylheterocyclen |
| US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| DE10253282A1 (de) | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung |
| DE102004003428A1 (de) | 2004-01-23 | 2005-08-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel |
| DE102004024454A1 (de) | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| US7220742B2 (en) | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| DE102004045648A1 (de) | 2004-09-21 | 2006-03-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Betamimetika zur Behandlung von Atemwegserkrankungen |
| JP2008532979A (ja) | 2005-03-10 | 2008-08-21 | ビーエーエスエフ ソシエタス・ヨーロピア | 有害菌類を防除するための４−アミノピリミジン類の使用、新規の４−アミノピリミジン類、それらを調製する方法およびそれらを含む組成物 |
| WO2007093608A1 (de) * | 2006-02-16 | 2007-08-23 | Boehringer Ingelheim International Gmbh | Arzneimittelkombinationen zur behandlung von atemwegserkrankungen |
| PE20080142A1 (es) | 2006-03-15 | 2008-04-14 | Boehringer Ingelheim Int | Beta-agonistas enantiomericamente puros y sus procedimientos de preparacion |
-
2007
- 2007-03-13 PE PE2007000271A patent/PE20080142A1/es not_active Application Discontinuation
- 2007-03-14 BR BRPI0709601-1A patent/BRPI0709601A2/pt not_active Application Discontinuation
- 2007-03-14 CA CA002643026A patent/CA2643026A1/en not_active Abandoned
- 2007-03-14 EA EA200801894A patent/EA200801894A1/ru unknown
- 2007-03-14 WO PCT/EP2007/052389 patent/WO2007104772A1/de active Application Filing
- 2007-03-14 KR KR1020087025108A patent/KR20080106973A/ko not_active Application Discontinuation
- 2007-03-14 AU AU2007224420A patent/AU2007224420A1/en not_active Abandoned
- 2007-03-14 JP JP2008558815A patent/JP2009530245A/ja active Pending
- 2007-03-14 MX MX2008011700A patent/MX2008011700A/es not_active Application Discontinuation
- 2007-03-14 AR ARP070101031A patent/AR059836A1/es not_active Suspension/Interruption
- 2007-03-14 TW TW096108791A patent/TW200804360A/zh unknown
- 2007-03-14 UY UY30207A patent/UY30207A1/es not_active Application Discontinuation
- 2007-03-14 EP EP07726883A patent/EP1996581A1/de not_active Withdrawn
- 2007-03-15 US US11/686,565 patent/US7534789B2/en not_active Expired - Fee Related
-
2008
- 2008-08-13 NO NO20083508A patent/NO20083508L/no not_active Application Discontinuation
- 2008-09-08 EC EC2008008723A patent/ECSP088723A/es unknown
-
2009
- 2009-04-07 US US12/419,505 patent/US7939658B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO20083508L (no) | 2008-09-30 |
| MX2008011700A (es) | 2008-09-24 |
| PE20080142A1 (es) | 2008-04-14 |
| TW200804360A (en) | 2008-01-16 |
| CA2643026A1 (en) | 2007-09-20 |
| AU2007224420A1 (en) | 2007-09-20 |
| US7534789B2 (en) | 2009-05-19 |
| US20070249595A1 (en) | 2007-10-25 |
| US20090306068A1 (en) | 2009-12-10 |
| UY30207A1 (es) | 2007-10-31 |
| EA200801894A1 (ru) | 2009-02-27 |
| JP2009530245A (ja) | 2009-08-27 |
| US7939658B2 (en) | 2011-05-10 |
| WO2007104772A1 (de) | 2007-09-20 |
| EP1996581A1 (de) | 2008-12-03 |
| BRPI0709601A2 (pt) | 2011-07-19 |
| ECSP088723A (es) | 2008-10-31 |
| WO2007104772A9 (de) | 2007-11-22 |
| KR20080106973A (ko) | 2008-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20191617T1 (hr) | Kombinacija koja sadrži inhibitor mek i inhibitor b-raf | |
| AR058082A1 (es) | Formulacion en aerosol para la inhalacion de beta- agonistas | |
| CO6170341A2 (es) | Formulacion de aerosol que contiene derivados de benzoxazin-3onas | |
| CY1118839T1 (el) | Επικαλυμμενη φαρμακευτικη συνθεση που περιεχει ρεγοραφενιμπη | |
| PE20191744A1 (es) | Derivados de tirosinamida como inhibidores de rho-quinasa | |
| JP2014511840A5 (es) | ||
| AR071577A1 (es) | Pirazolo-pirimidinona para el tratamiento de trastornos del sistema nervioso central | |
| AR082015A1 (es) | Derivados de metoxifenilo heterociclicamente sustituidos con un grupo oxo, procedimientos para su preparacion y uso de los mismos como medicamentos | |
| AR085960A1 (es) | 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2 | |
| HRP20140814T1 (hr) | Inhibitori jak2 i njihova uporaba za lijeäśenje mijeloproliferativnih bolesti i karcinoma | |
| AR053092A1 (es) | Compuestos derivados de acido fenoxiacetico y compuestos intermediarios de sintesis | |
| AR059727A1 (es) | Moduladores de 11- beta hidroxil esteriode deshidrogenasa de tipo 1, composiciones farmaceuticas de los mismos , y metodos de uso de los mismos | |
| AR067461A1 (es) | Derivado del acido pirrolidin propanoico, productos farmaceuticos que lo contienen, proceso de preparacion y uso de los mismos para el tratamiento de trastornos respiratorios. | |
| AR040352A1 (es) | Derivados de indolinfenilsulfonamida | |
| ECSP11010857A (es) | Nuevas benzamidas, su preparación y su uso como medicamentos | |
| AR094997A1 (es) | Sales y formas sólidas de (s)-3-(4-((4-(morfolinometil)bencil)oxi)-1-oxoisoindolin-2-il)piperidin-2,6-diona y composiciones que las comprenden y sus usos | |
| AR078164A1 (es) | Derivados de isoxazolidina, proceso para preparar dichos compuestos y composiciones farmaceuticas que los comprenden | |
| AR072994A1 (es) | Derivados de carbonato de quinuclidina y composicion medicinal de los mismos | |
| AR083026A1 (es) | Derivados de ciclohexenona y composiciones para el tratamiento del cancer de pulmon | |
| EA201792072A2 (ru) | Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения | |
| AR090350A1 (es) | Compuestos quimicos | |
| AR073043A1 (es) | Compuestos de azetidinas polisustituidos, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de los mismos en el tratamiento de enfermedades respiratorias, metabolicas y del sistema nervioso central, entre otras. | |
| AR116880A1 (es) | Compuestos de pirimidinodiona bicíclicos sustituidos con tetrahidropirano, forma polimórfica del mismo y el uso de los mismos para el tratamiento del hcm | |
| AR059836A1 (es) | Beta-agonistas enantiomericamente puros, y su uso como medicamentos | |
| PE20181017A1 (es) | Compuestos heteroarilo y su uso como farmacos terapeuticos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |